- Advertisement -

Pharmaceutical manufacturer and medicinal cannabis group IDT Australia (ASX: IDT) has sweetened the pot for potential international suitor Myndbio after reporting a 92 per cent lift in revenue for FY24.
IDT, which revealed last month it received a non-binding indicative takeover bid from Myndbio…

